Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUCB Infusion in Acute Ischemic Stroke
NCT06040476Phase 2Not yet recruiting
- Sponsor
- StemCyte Inc.
- Start
- Sep 2025
- Primary completion
- Dec 2027
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of allogeneic human umbilical cord blood in ischemic stroke, sponsored by StemCyte Inc.. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
allogeneic human umbilical cord blood
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06040476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06040476.